Cargando…

Comparison between the modified long gonadotropin-releasing hormone agonist protocol and the non-downregulation protocol in POSEIDON groups: a propensity score matching retrospective cohort study

BACKGROUND: In vitro fertilization (IVF) is the main technique to address the infertility issue in the patient-oriented strategy encompassing individualized oocyte number (POSEIDON) population. Adopting appropriate protocols for assisted reproduction technologies (ART) cycles in the POSEIDON group m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chunyan, Zeng, Xinliu, Zhang, Hanke, Wei, Qiongqiong, Gao, Ying, Liu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666785/ https://www.ncbi.nlm.nih.gov/pubmed/38027212 http://dx.doi.org/10.3389/fendo.2023.1189357

Ejemplares similares

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study
por: Drakopoulos, Panagiotis, et al.
Publicado: (2019)

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4
por: Tan, Jifan, et al.
Publicado: (2023)

Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors
por: Finch, Ann R., et al.
Publicado: (2009)

Analysis of the Number of Euploid Embryos in Preimplantation Genetic Testing Cycles With Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol
por: Li, Gang, et al.
Publicado: (2020)

Analysis of relative factors and prediction model for optimal ovarian response with gonadotropin-releasing hormone antagonist protocol
por: Jiang, Wenwen, et al.
Publicado: (2022)

Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients
por: Martazanova, Bella, et al.
Publicado: (2022)

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria
por: Liu, Xueying, et al.
Publicado: (2021)

The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty
por: Tseng, Chin-Hui, et al.
Publicado: (2023)

Epigenetic Control of Gonadotropin Releasing Hormone Neurons
por: Kurian, Joseph R., et al.
Publicado: (2013)

Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations
por: Zhou, Ruiqiong, et al.
Publicado: (2023)

Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
por: Ji, Hui, et al.
Publicado: (2022)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
por: Merkison, Jamie, et al.
Publicado: (2022)

Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
por: Bjelobaba, Ivana, et al.
Publicado: (2018)

Semaphorin Signaling in the Development and Function of the Gonadotropin Hormone-Releasing Hormone System
por: Messina, Andrea, et al.
Publicado: (2013)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
por: Zhao, Shen, et al.
Publicado: (2023)

Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
por: Lawrenz, Barbara, et al.
Publicado: (2018)

Management Strategies for POSEIDON's Group 1
por: Polyzos, Nikolaos P., et al.
Publicado: (2019)

Management Strategies for POSEIDON Group 2
por: Sunkara, Sesh Kamal, et al.
Publicado: (2020)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls
por: Choi, Yujung, et al.
Publicado: (2019)

Gonadotropin-Releasing Hormone and Its Role in the Enteric Nervous System
por: Ohlsson, Bodil
Publicado: (2017)

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
por: Gründker, Carsten, et al.
Publicado: (2017)

Invertebrate Gonadotropin-Releasing Hormone-Related Peptides and Their Receptors: An Update
por: Sakai, Tsubasa, et al.
Publicado: (2017)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With “Unpredictable” Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol
por: Zhang, Chunhui, et al.
Publicado: (2021)

SAT-304 Unexplained Asymptomatic Hyperestrogenism in Central Precocious Puberty Patient Treated with Gonadotropin Releasing Hormone Agonist
por: Kim, Dae Hyun, et al.
Publicado: (2019)

Early Development of the Gonadotropin-Releasing Hormone Neuronal Network in Transgenic Zebrafish
por: Zhao, Yali, et al.
Publicado: (2013)

Expression and Role of Gonadotropin-Releasing Hormone 2 and Its Receptor in Mammals
por: Desaulniers, Amy T., et al.
Publicado: (2017)

Progress and Challenges in the Search for the Mechanisms of Pulsatile Gonadotropin-Releasing Hormone Secretion
por: Constantin, Stephanie
Publicado: (2017)

Effects of Social Information on the Release and Expression of Gonadotropin-Inhibitory Hormone in Birds
por: Tobari, Yasuko, et al.
Publicado: (2019)

Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders
por: Liu, Yuan, et al.
Publicado: (2021)

Gonadotropin-Releasing Hormone and Adipokinetic Hormone Signaling Systems Share a Common Evolutionary Origin
por: Lindemans, Marleen, et al.
Publicado: (2011)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Bühler, Klaus F.
Publicado: (2020)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Fischer, Robert, et al.
Publicado: (2020)

SAT-291 Gonadotropin Releasing Hormone Agonist Therapy Improves Hyperandrogenism in an Adolescent with Type A Insulin Resistance Syndrome
por: Paprocki, Emily, et al.
Publicado: (2019)

Molecular Mechanisms of Gonadotropin-Releasing Hormone Signaling: Integrating Cyclic Nucleotides into the Network
por: Perrett, Rebecca M., et al.
Publicado: (2013)

Afferent Neuronal Control of Type-I Gonadotropin Releasing Hormone Neurons in the Human
por: Hrabovszky, Erik, et al.
Publicado: (2013)

Gonadotropin-releasing hormone 2 suppresses food intake in the zebrafish, Danio rerio
por: Nishiguchi, Ryo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_di7i7cunae8e1fv1omlj9igeg7